Cytotoxic T lymphocyte‐associated antigen‐4 (CTLA-4) gene polymorphisms in a cohort of Egyptian patients with immune thrombocytopenia (ITP)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Cytotoxic T lymphocyte‐associated antigen‐4 (CTLA-4) gene polymorphisms in a cohort of Egyptian patients with immune thrombocytopenia (ITP) ; volume:59 ; number:1 ; day:1 ; month:3 ; year:2024 ; pages:1-8 ; date:12.2024
Blood research ; 59, Heft 1 (1.3.2024), 1-8, 12.2024
- Creator
-
El Demerdash, Doaa Mohamed
Saber, Maha Mohamed
Ayad, Alia
Gomaa, Kareeman
Abdelkader Morad, Mohamed
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s44313-024-00011-z
- URN
-
urn:nbn:de:101:1-2405052147319.955745198498
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- El Demerdash, Doaa Mohamed
- Saber, Maha Mohamed
- Ayad, Alia
- Gomaa, Kareeman
- Abdelkader Morad, Mohamed
- SpringerLink (Online service)
Other Objects (12)
Targeting cytotoxic lymphocyte antigen 4 (CTLA-4) in breast cancer
Immune thrombocytopenia (ITP)
Immune thrombocytopenia (ITP)
Immune thrombocytopenia (ITP)
The role of cytotoxic T lymphocyte antigen 4 (CTLA-4) in atherosclerosis
Cytotoxic T lymphocyte antigen-4 (CTLA-4) als therapeutisches Target in der Tumorimmuntherapie
Immune thrombocytopenia (ITP): historical perspectives, pathophysiology, and treatment advances
Primary versus Secondary Immune Thrombocytopenia (ITP): A Meeting Report from the 2023 McMaster ITP Summit
Cytotoxic T lymphocyte responses against melanocytes and melanoma
High Glucose Enhances Cytotoxic T Lymphocyte-Mediated Cytotoxicity
Soluble cytotoxic T-lymphocyte–associated antigen 4 (sCTLA-4) as a potential biomarker for diagnosis and evaluation of the prognosis in Glioma
Granzyme B; the chalk-mark of a cytotoxic lymphocyte
Targeting cytotoxic lymphocyte antigen 4 (CTLA-4) in breast cancer
Immune thrombocytopenia (ITP)
Immune thrombocytopenia (ITP)
Immune thrombocytopenia (ITP)
The role of cytotoxic T lymphocyte antigen 4 (CTLA-4) in atherosclerosis
Cytotoxic T lymphocyte antigen-4 (CTLA-4) als therapeutisches Target in der Tumorimmuntherapie
Immune thrombocytopenia (ITP): historical perspectives, pathophysiology, and treatment advances
Primary versus Secondary Immune Thrombocytopenia (ITP): A Meeting Report from the 2023 McMaster ITP Summit
Cytotoxic T lymphocyte responses against melanocytes and melanoma
High Glucose Enhances Cytotoxic T Lymphocyte-Mediated Cytotoxicity
Soluble cytotoxic T-lymphocyte–associated antigen 4 (sCTLA-4) as a potential biomarker for diagnosis and evaluation of the prognosis in Glioma
Granzyme B; the chalk-mark of a cytotoxic lymphocyte
Targeting cytotoxic lymphocyte antigen 4 (CTLA-4) in breast cancer
Immune thrombocytopenia (ITP)
Immune thrombocytopenia (ITP)
Immune thrombocytopenia (ITP)
The role of cytotoxic T lymphocyte antigen 4 (CTLA-4) in atherosclerosis
Cytotoxic T lymphocyte antigen-4 (CTLA-4) als therapeutisches Target in der Tumorimmuntherapie
Immune thrombocytopenia (ITP): historical perspectives, pathophysiology, and treatment advances
Primary versus Secondary Immune Thrombocytopenia (ITP): A Meeting Report from the 2023 McMaster ITP Summit
Cytotoxic T lymphocyte responses against melanocytes and melanoma
High Glucose Enhances Cytotoxic T Lymphocyte-Mediated Cytotoxicity
Soluble cytotoxic T-lymphocyte–associated antigen 4 (sCTLA-4) as a potential biomarker for diagnosis and evaluation of the prognosis in Glioma